Mayo Clinic, GE-backed startup secures $13.7M in Series A funding

San Francisco-based Vineti — a startup that leverages logistics, manufacturing and clinical data to improve patient access to cell and gene therapies — raised $13.75 million in Series A funding.

Advertisement

The funding included input from returning investors and cofounders GE Ventures and Mayo Clinic Ventures, along with new investments from DFJ and LifeForce Capital.

GE Ventures and Mayo Clinic Ventures launched the cloud-based Vineti platform to automate the production and delivery of individualized therapies. Vineti will use the Series A funding to grow its team and promote safety and regulatory compliance for cell therapies.

More articles on health IT:
How informatics led Dr. Don Rucker to head ONC
Health IT company CoPilot agrees to $130k settlement after delayed breach notification
DOD needs top talent to address cyberthreats, acting CIO says

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.